Trial Details
RecruitingBasic Information
| Clinical ID | c2085 |
|---|---|
| Identifier | CTIS2023-508224-35-01 |
| Trial Title | Analgesic effect of intravenous lidocaine and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Linisol 1 %, solution injectable, Product Code:PRD5359608, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: NaCl 0,9 % B. Braun, solution pour perfusion, Product Code:PRD5372764, Pharmaceutical Form: SOLUTION FOR INJECTION/INFUSION, Other descriptive name: , Strength: , Pharmaceutical form of the placebo: SOLUTION FOR INJECTION/INFUSION |
Participant Information
| Sponsor | CHU De Liege |
|---|---|
| City | - |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |